Recorded on 07/10/25

TD Cowen's Life Science Tools & Diagnostics analysts Dan Brennan and Brendan Smith discuss the current and future outlook of the Tools/Dx sector as a wrap-up to The 4th Annual Tools/Dx Revolution Conference featuring a broad spectrum of executives and industry insiders from leading public and private players in the space. The team dives into key themes and critical investment topics across the sector and sheds light on lessons learned, the path forward for the space, and strategies to differentiate the leaders from the laggards.

Panel highlights include salient commentary pertaining to everything AI (which permeated every panel), company strategy (to navigate the challenging times), lessons learned (from industry vets about assessing the current environment to past periods), how Pharma is looking to improve R&D productivity, optimizing products/strategy for the Longevity wave, and the oncology Dx business models (particularly as competition intensifies). Though the Tools sector has seen challenges in recent years, confidence in the long-term vibrancy of the sector is evident, coupled with enthusiasm for the Dx and AI spaces that are experiencing numerous tailwinds.

https://go.td.com/PodcastDisclosure